Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1062 | 1062 | 1116 | 1290 | - | - |
Fund Return | 6.17% | 6.17% | 11.56% | 8.86% | - | - |
Place in category | 1602 | 1602 | 1381 | 478 | - | - |
% in Category | 74 | 74 | 70 | 28 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Santander Select Decidido S FI | 6.59B | 3.54 | 0.45 | 2.77 | ||
Santander Select Decidido A FI | 6.59B | 3.54 | 0.45 | 2.64 | ||
Santander 100 Valor Creciente 2 FI | 3.39B | 1.86 | 0.12 | - | ||
Santander Select Patrimonio S FI | 2.94B | 1.66 | -1.09 | -0.01 | ||
Santander Select Patrimonio A FI | 2.94B | 1.66 | -1.09 | -0.14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JP Europe Equity Plus D Perf Acc | 1.86B | 12.74 | 10.88 | 6.41 | ||
ES0137509008 | 383.65M | 8.54 | 11.31 | - | ||
ES0114564000 | 283.38M | 7.68 | 9.39 | - | ||
BBVA Bolsa Europa FI | 393.81M | 1.92 | 8.23 | 4.06 | ||
BBVA Bolsa Euro FI | 109.17M | 7.99 | 8.26 | 4.41 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Fut. Swiss Mkt Ix 03/24 | DE000C6XKEB4 | 5.28 | - | - | |
Novo Nordisk B | DK0062498333 | 5.22 | 886.6 | +2.28% | |
AstraZeneca | GB0009895292 | 3.22 | 11,988.0 | -0.32% | |
ASML Holding | NL0010273215 | 3.02 | 858.80 | +3.22% | |
Roche Holding Participation | CH0012032048 | 2.55 | 221.00 | +1.01% |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review